Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TLN | CEG |
|---|---|---|
| Price | $323.58 | $259.00 |
| Change today | ▲ 3.48% | ▲ 1.96% |
| Market cap | $15.50B | $91.77B |
| Return, 3 months | -10.3% | +9.7% |
| Return, year to date | -13.7% | -26.4% |
| Return, 1 year | -24.2% | -25.8% |
| P/E (TTM) | -80.1 | 25.3 |
| P/B | 9.6 | 2.9 |
| P/E percentile vs own 5y | 12th | 43rd |
| Dividend yield | – | 0.63% |
| Revenue growth (YoY, latest qtr) | +111.2% | +23.0% |
| Net profit growth (YoY) | -227.8% | -39.0% |
| Gross margin | 42.1% | 21.4% |
| Operating margin | 12.5% | 17.8% |
| Net margin | -4.9% | 11.1% |
| Return on equity | -12.9% | 15.3% |
| Analyst target vs. price | +41.6% | +36.3% |
| Analyst buy share | 83% | 88% |
| RSI (14) | 52 | 39 |
| 30-day volatility | 39.6% | 37.9% |
| Max drawdown, 1 year | -36.7% | -41.2% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
